参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/11 | 1,829 | 1,829 | 1,797 | 1,802 | -15 | -0.8% | 626,400 |
2018/12/10 | 1,846 | 1,846 | 1,808 | 1,817 | -53 | -2.8% | 764,200 |
2018/12/07 | 1,866 | 1,879 | 1,849 | 1,870 | +19 | +1% | 880,100 |
2018/12/06 | 1,877 | 1,893 | 1,832 | 1,851 | -61 | -3.2% | 1,019,700 |
2018/12/05 | 1,864 | 1,918 | 1,863 | 1,912 | +12 | +0.6% | 740,600 |
2018/12/04 | 1,930 | 1,937 | 1,900 | 1,900 | -47 | -2.4% | 830,300 |
2018/12/03 | 1,973 | 1,988 | 1,938 | 1,947 | +4 | +0.2% | 1,003,200 |
2018/11/30 | 1,897 | 1,945 | 1,890 | 1,943 | +6 | +0.3% | 1,775,500 |
2018/11/29 | 1,910 | 1,957 | 1,909 | 1,937 | +61 | +3.3% | 1,133,400 |
2018/11/28 | 1,890 | 1,907 | 1,874 | 1,876 | +32 | +1.7% | 1,378,100 |
2018/11/27 | 1,866 | 1,866 | 1,836 | 1,844 | -23 | -1.2% | 607,800 |
2018/11/26 | 1,850 | 1,873 | 1,850 | 1,867 | +17 | +0.9% | 743,400 |
2018/11/22 | 1,806 | 1,856 | 1,806 | 1,850 | +56 | +3.1% | 777,500 |
2018/11/21 | 1,774 | 1,800 | 1,771 | 1,794 | -8 | -0.4% | 785,000 |
2018/11/20 | 1,827 | 1,831 | 1,795 | 1,802 | -45 | -2.4% | 1,131,500 |
2018/11/19 | 1,843 | 1,851 | 1,825 | 1,847 | -12 | -0.6% | 891,400 |
2018/11/16 | 1,838 | 1,871 | 1,829 | 1,859 | +31 | +1.7% | 938,800 |
2018/11/15 | 1,791 | 1,834 | 1,780 | 1,828 | +21 | +1.2% | 958,300 |
2018/11/14 | 1,832 | 1,841 | 1,804 | 1,807 | -42 | -2.3% | 1,502,500 |
2018/11/13 | 1,834 | 1,855 | 1,814 | 1,849 | -21 | -1.1% | 1,167,800 |
2018/11/12 | 1,839 | 1,877 | 1,821 | 1,870 | +15 | +0.8% | 1,116,800 |
2018/11/09 | 1,826 | 1,868 | 1,826 | 1,855 | +43 | +2.4% | 1,730,700 |
2018/11/08 | 1,756 | 1,826 | 1,726 | 1,812 | +109 | +6.4% | 2,647,300 |
2018/11/07 | 1,715 | 1,725 | 1,692 | 1,703 | -21 | -1.2% | 1,298,000 |
2018/11/06 | 1,669 | 1,731 | 1,669 | 1,724 | +43 | +2.6% | 1,204,800 |
2018/11/05 | 1,692 | 1,698 | 1,669 | 1,681 | -13 | -0.8% | 833,100 |
2018/11/02 | 1,683 | 1,702 | 1,674 | 1,694 | +22 | +1.3% | 1,283,000 |
2018/11/01 | 1,673 | 1,688 | 1,663 | 1,672 | -3 | -0.2% | 1,315,600 |
2018/10/31 | 1,667 | 1,690 | 1,646 | 1,675 | +19 | +1.1% | 1,709,200 |
2018/10/30 | 1,620 | 1,661 | 1,620 | 1,656 | +13 | +0.8% | 1,191,300 |
2018/10/29 | 1,655 | 1,669 | 1,639 | 1,643 | +12 | +0.7% | 819,300 |
2018/10/26 | 1,661 | 1,663 | 1,613 | 1,631 | -24 | -1.5% | 1,356,700 |
2018/10/25 | 1,680 | 1,701 | 1,652 | 1,655 | -57 | -3.3% | 1,219,000 |
2018/10/24 | 1,702 | 1,730 | 1,680 | 1,712 | +21 | +1.2% | 1,559,700 |
2018/10/23 | 1,744 | 1,756 | 1,690 | 1,691 | -73 | -4.1% | 990,100 |
2018/10/22 | 1,745 | 1,774 | 1,740 | 1,764 | +4 | +0.2% | 1,038,200 |
2018/10/19 | 1,766 | 1,766 | 1,746 | 1,760 | -6 | -0.3% | 1,121,500 |
2018/10/18 | 1,765 | 1,786 | 1,756 | 1,766 | +23 | +1.3% | 1,174,200 |
2018/10/17 | 1,733 | 1,749 | 1,728 | 1,743 | +33 | +1.9% | 788,800 |
2018/10/16 | 1,701 | 1,727 | 1,697 | 1,710 | +11 | +0.6% | 1,078,500 |
2018/10/15 | 1,708 | 1,721 | 1,692 | 1,699 | -29 | -1.7% | 1,160,400 |
2018/10/12 | 1,692 | 1,744 | 1,684 | 1,728 | +12 | +0.7% | 1,752,500 |
2018/10/11 | 1,736 | 1,748 | 1,707 | 1,716 | -60 | -3.4% | 1,388,800 |
2018/10/10 | 1,752 | 1,785 | 1,748 | 1,776 | +32 | +1.8% | 1,117,500 |
2018/10/09 | 1,788 | 1,802 | 1,740 | 1,744 | -41 | -2.3% | 1,256,200 |
2018/10/05 | 1,810 | 1,810 | 1,782 | 1,785 | -35 | -1.9% | 968,500 |
2018/10/04 | 1,850 | 1,859 | 1,817 | 1,820 | -22 | -1.2% | 1,949,100 |
2018/10/03 | 1,857 | 1,869 | 1,842 | 1,842 | -22 | -1.2% | 1,115,700 |
2018/10/02 | 1,860 | 1,883 | 1,853 | 1,864 | +39 | +2.1% | 1,498,200 |
2018/10/01 | 1,835 | 1,852 | 1,816 | 1,825 | +24 | +1.3% | 1,274,500 |
1451~
1500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム